Common Causes of Blood Transfusion Events in a University Hospital: Analysis of Incident Reports

March 13, 2013 updated by: Universitaire Ziekenhuizen KU Leuven

Common Causes of Blood Transfusion Events in a University Hospital: Analysis of Incident Reports.

Inhospital the blood transfusion process consists of many phases: ordering the blood product, analysis of the blood sample, delivery, transport and storage of the blood product and administration. In each of these phases (near) accidents may occur. A severe transfusion incident refers to the transfusion of a wrong blood product, whereas a near miss is detected before transfusion.

In 2010 the University Hospitals Leuven introduced a new electronic patient incident report system for transfusion events.

In this study the investigators will analyze the reported blood transfusion events to detect the most common causes of blood transfusion events and the weakest link in the blood transfusion chain.

Study Overview

Status

Completed

Detailed Description

A retrospective survey will be conducted of all transfusion events reported in the University Hospitals Leuven between January 2011 and July 2012. Both severe accidents and near misses will be included.

Data will be drawn from the incident report system. Data concerning the number of transfused blood products will be required from the Medical Administration Service.

Events will be classified according to the severity and the cause of the event. The different settings where the events took place will be compared using a chi-square test (p<0,05).

Study Type

Observational

Enrollment (Actual)

131

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium
        • University Hospitals Leuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients in a university hospital which experienced a transfusion event

Description

Inclusion Criteria:

  • all transfusion events reported in the University Hospitals Leuven between January 2011 and July 2012
  • Both severe accidents and near misses were included

Exclusion Criteria:

  • Transfusion reactions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity of inhospital blood transfusion events
Time Frame: up to 1,5 years
included events will be classified into near misses or severe incidents
up to 1,5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Causes of inhospital blood transfusion events
Time Frame: up to 1,5 years

Events are classified into human error, technical problems, deficiency of the blood product and others.

Events will also be classified considering the phase in the blood transfusion process.

Causes will be studied hospital wide and per setting were the event took place.

up to 1,5 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of inhospital blood transfusion events
Time Frame: up to 1,5 years
The number of transfusion events divided by the total number of transfused blood products in the study period
up to 1,5 years
Is there a relation between misidentification events and the setting where the event took place?
Time Frame: up to 1,5 years
The different settings where the events took place will be compared using a chi-square test (p<0,05).
up to 1,5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Timothy Devos, MD, PhD, Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
  • Principal Investigator: Els Costermans, RN, Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (ACTUAL)

February 1, 2013

Study Registration Dates

First Submitted

February 12, 2013

First Submitted That Met QC Criteria

March 13, 2013

First Posted (ESTIMATE)

March 18, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

March 18, 2013

Last Update Submitted That Met QC Criteria

March 13, 2013

Last Verified

February 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • S55141

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Transfusion Events

3
Subscribe